share_log

Little Excitement Around Agenus Inc.'s (NASDAQ:AGEN) Revenues As Shares Take 42% Pounding

Little Excitement Around Agenus Inc.'s (NASDAQ:AGEN) Revenues As Shares Take 42% Pounding

Agenus Inc. 周围有点兴奋。”s(纳斯达克股票代码:AGEN)股价暴跌42%的收入
Simply Wall St ·  03/16 09:43

Agenus Inc. (NASDAQ:AGEN) shares have had a horrible month, losing 42% after a relatively good period beforehand.    For any long-term shareholders, the last month ends a year to forget by locking in a 68% share price decline.  

Agenus Inc.(纳斯达克股票代码:AGEN)的股价经历了一个糟糕的月份,在经历了相对不错的时期之后下跌了42%。对于任何长期股东来说,最后一个月的股价下跌幅度为68%,从而结束了令人难忘的一年。

After such a large drop in price, Agenus may be sending very bullish signals at the moment with its price-to-sales (or "P/S") ratio of 1.4x, since almost half of all companies in the Biotechs industry in the United States have P/S ratios greater than 15.2x and even P/S higher than 72x are not unusual.   Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly reduced P/S.  

在价格大幅下跌之后,Agenus目前可能发出了非常看涨的信号,其市销率(或 “市盈率”)为1.4倍,因为美国生物技术行业几乎有一半的公司市盈率大于15.2倍,甚至市盈率高于72倍也并不少见。但是,我们需要更深入地挖掘,以确定大幅降低市销率是否有合理的基础。

NasdaqCM:AGEN Price to Sales Ratio vs Industry March 16th 2024

纳斯达克股票代码:AGEN与行业的股价销售比率 2024年3月16日

How Agenus Has Been Performing

Agenus 的表现如何

With revenue growth that's inferior to most other companies of late, Agenus has been relatively sluggish.   The P/S ratio is probably low because investors think this lacklustre revenue performance isn't going to get any better.  If this is the case, then existing shareholders will probably struggle to get excited about the future direction of the share price.    

由于最近的收入增长不如大多数其他公司,Agenus一直相对疲软。市销率可能很低,因为投资者认为这种乏善可陈的收入表现不会好转。如果是这样的话,那么现有股东可能很难对股价的未来走向感到兴奋。

Want the full picture on analyst estimates for the company? Then our free report on Agenus will help you uncover what's on the horizon.  

想全面了解分析师对公司的估计吗?然后,我们关于Agenus的免费报告将帮助您发现即将发生的事情。

Is There Any Revenue Growth Forecasted For Agenus?  

预计Agenus的收入会增长吗?

The only time you'd be truly comfortable seeing a P/S as depressed as Agenus' is when the company's growth is on track to lag the industry decidedly.  

只有当公司的增长有望明显落后于该行业时,你才能真正放心地看到像Agenus一样低迷的市销率。

If we review the last year of revenue growth, the company posted a terrific increase of 59%.   The strong recent performance means it was also able to grow revenue by 77% in total over the last three years.  So we can start by confirming that the company has done a great job of growing revenue over that time.  

如果我们回顾一下去年的收入增长,该公司公布了59%的惊人增长。最近的强劲表现意味着它在过去三年中总收入增长了77%。因此,我们可以首先确认该公司在这段时间内在增加收入方面做得很好。

Looking ahead now, revenue is anticipated to climb by 24% per annum during the coming three years according to the five analysts following the company.  Meanwhile, the rest of the industry is forecast to expand by 197% each year, which is noticeably more attractive.

现在展望未来,根据关注该公司的五位分析师的说法,预计未来三年收入将每年增长24%。同时,该行业的其他部门预计每年将增长197%,这明显更具吸引力。

In light of this, it's understandable that Agenus' P/S sits below the majority of other companies.  Apparently many shareholders weren't comfortable holding on while the company is potentially eyeing a less prosperous future.  

有鉴于此,Agenus的市销率低于其他多数公司是可以理解的。显然,许多股东不愿坚持下去,而该公司可能正在考虑不那么繁荣的未来。

The Key Takeaway

关键要点

Shares in Agenus have plummeted and its P/S has followed suit.      It's argued the price-to-sales ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

Agenus的股价暴跌,其市销率也紧随其后。有人认为,在某些行业中,市销率是衡量价值的较差指标,但它可以是一个有力的商业信心指标。

We've established that Agenus maintains its low P/S on the weakness of its forecast growth being lower than the wider industry, as expected.  Right now shareholders are accepting the low P/S as they concede future revenue probably won't provide any pleasant surprises.  Unless these conditions improve, they will continue to form a barrier for the share price around these levels.    

我们已经确定,Agenus维持其较低的市销率,原因是其预期的增长率低于整个行业。目前,股东们正在接受低市销率,因为他们承认未来的收入可能不会带来任何惊喜。除非这些条件有所改善,否则它们将继续构成股价在这些水平附近的障碍。

We don't want to rain on the parade too much, but we did also find 5 warning signs for Agenus (1 shouldn't be ignored!) that you need to be mindful of.  

我们不想在游行队伍中下太多雨,但我们也发现了 Agenus 的 5 个警告标志(1 个不容忽视!)这是你需要注意的。

If companies with solid past earnings growth is up your alley, you may wish to see this free collection of other companies with strong earnings growth and low P/E ratios.

如果过去盈利增长稳健的公司处于困境,那么你可能希望看到这些盈利增长强劲、市盈率低的其他公司的免费集合。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接联系我们。或者,也可以发送电子邮件至编辑团队 (at) simplywallst.com。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发